These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2436774)
61. Immunocytochemical detection of carcinoembryonic antigen in fine-needle aspirates from patients with diverse breast diseases. Alexiev BA; Valkov IN; Popov AA; Marinov VS Diagn Cytopathol; 1993 Aug; 9(4):377-82. PubMed ID: 8261842 [TBL] [Abstract][Full Text] [Related]
62. Carcinoembryonic antigen and ferritin in patients with lung cancer before and during therapy. Gropp C; Havemann K; Lehmann FG Cancer; 1978 Dec; 42(6):2802-8. PubMed ID: 728875 [TBL] [Abstract][Full Text] [Related]
63. Cytochemical and competitive protein binding assays for estrogen receptor in breast disease. A comparative study of 62 cases. Jacobs SR; Wolfson WL; Cheng L; Lewin KJ Cancer; 1983 May; 51(9):1621-4. PubMed ID: 6831365 [TBL] [Abstract][Full Text] [Related]
64. Steroid patterns of benign breast disease. Castagnetta L; Granata OM; Brignone G; Blasi L; Arcuri F; Mesiti M; D'Aquino A; Preitano W Ann N Y Acad Sci; 1990; 586():121-36. PubMed ID: 2141455 [TBL] [Abstract][Full Text] [Related]
65. Immunohistologic detection of estrogen receptors in paraffin-embedded breast cancers: correlation with cytosol measurements. Pascal RR; Santeusanio G; Sarrell D; Johnson CE Hum Pathol; 1986 Apr; 17(4):370-5. PubMed ID: 3007325 [TBL] [Abstract][Full Text] [Related]
66. Histological detection of oestrogen receptor in human breast carcinomas. Walker RA; Cove DH; Howell A Lancet; 1980 Jan; 1(8161):171-3. PubMed ID: 6153438 [TBL] [Abstract][Full Text] [Related]
67. Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue. Rossiello R; Carriero MV; Giordano GG J Clin Pathol; 1984 Jan; 37(1):51-5. PubMed ID: 6323544 [TBL] [Abstract][Full Text] [Related]
68. Correlation of estrogen receptor level and lipid staining in breast carcinoma. Rashid RK; Gallager HS Arch Pathol Lab Med; 1984 Sep; 108(9):707-9. PubMed ID: 6547823 [TBL] [Abstract][Full Text] [Related]
69. Characterization of cell types in human breast tumor primary cultures. Muller D; Fricker JP; Millon-Collard R; Abecassis J; Pusel J; Eber M; Methlin G Biol Cell; 1987; 61(1-2):91-9. PubMed ID: 2451960 [TBL] [Abstract][Full Text] [Related]
70. A case of intracystic carcinoma of the breast: the importance of measuring carcinoembryonic antigen in aspirated cystic fluid. Matsuo S; Eto T; Soejima H; Ohara O; Hidaka O; Miyazaki J; Tsunoda T; Kanematsu T Breast Cancer Res Treat; 1993 Oct; 28(1):41-4. PubMed ID: 8123868 [TBL] [Abstract][Full Text] [Related]
71. [New technology and prospects in the field of cytodiagnosis. B. Immunohistocytochemical findings on tumor makers]. Yamamoto Y; Watanabe K Rinsho Byori; 1985 Jul; Spec No 64():130-9. PubMed ID: 2415721 [No Abstract] [Full Text] [Related]
72. Tumor marker expression in breast carcinomas and relationship to prognosis. An immunohistochemical study. Lee AK; Rosen PP; DeLellis RA; Saigo PE; Gangi MD; Groshen S; Bagin R; Wolfe HJ Am J Clin Pathol; 1985 Dec; 84(6):687-96. PubMed ID: 3878077 [TBL] [Abstract][Full Text] [Related]
73. Axillary versus peripheral blood levels of sialic acid, ferritin, and CEA in patients with breast cancer. Monti M; Catania S; Locatelli E; Gandini R; Reggiani A; Cunietti E Breast Cancer Res Treat; 1990 Dec; 17(2):77-82. PubMed ID: 2096995 [TBL] [Abstract][Full Text] [Related]
74. PAP immunoperoxidase method demonstrating endogenous estrogen in breast carcinomas. Shimizu M; Wajima O; Miura M; Katayama I Cancer; 1983 Aug; 52(3):486-92. PubMed ID: 6407748 [TBL] [Abstract][Full Text] [Related]
75. Detection of alpha-lactalbumin in breast lesions and relationship to estrogen receptors and serum prolactin. Bahu RM; Mangkornkanok-Mark M; Albertson D; Fors E; Molteni A; Battifora H Cancer; 1980 Oct; 46(8):1775-80. PubMed ID: 6253044 [TBL] [Abstract][Full Text] [Related]
76. Immunodiagnostic test for the early detection of carcinoma of the breast. Giler S; Kupfer B; Urca I; Moroz C Surg Gynecol Obstet; 1979 Nov; 149(5):655-7. PubMed ID: 315619 [TBL] [Abstract][Full Text] [Related]
77. [Importance of the simultaneous determination of CEA, AFP, ferritin and beta 2 microglobulin in women with breast neoplasms. Preliminary results]. Ruibal A; Monné J; Soriano B; Solé LA; Rubio D Med Clin (Barc); 1979 Nov; 73(9):296-7. PubMed ID: 93672 [No Abstract] [Full Text] [Related]
78. [Preliminary results of the analysis of the carcinoembryonic antigen (CEA) level in the serum of patients with dysplasias and benign neoplasms of the breast]. Słuszniak J; Zagała A; Góźdź S; Bukowski J; Kowalski D; Korejba W; Banasińska E; Urbaniak A Nowotwory; 1986; 36(3):187-90. PubMed ID: 3822849 [No Abstract] [Full Text] [Related]
79. [Preliminary observations on the behavior of serum ferritin in female patients with breast cancer at various stages of the disease]. Dell'Anna B; Carnevali C; Crialesi Esposito G; Percudani M Acta Biomed Ateneo Parmense; 1982; 53(3):147-51. PubMed ID: 6216702 [TBL] [Abstract][Full Text] [Related]
80. Breast carcinoma-associated antigen. An immunocytochemical study. Yu GS; Kadish AS; Johnson AB; Marcus DM Am J Clin Pathol; 1980 Oct; 74(4):453-7. PubMed ID: 6999888 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]